Clinical Application of Serum Fructosamine Measurement as an Indicator of Blood Glucose Control

抄録

We investigated the problems associated with the assay of fructosamine as an indicator of blood glucose control. In light of the relationships among fasting blood glucose, levels of hemoglobin A_1c, and serum fructosamine, this assay appears to be clinically applicable for use as an indicator of blood glucose control during the two weeks prior to the assay. When blood glucose control is undertaken and serum fructosamine is used as an indicator, a serum fructosamine level of 3.1mmol/L is considered to an appropriate target level, except in patients with unstable diabetes, as compared with 2.56±0.30 mmol/L in healthy subjects.